Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Cancer Pain

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Cancer Pain in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Cancer Pain: Pain that may be caused by or related to cellular, tissue, and systemic changes that occur during NEOPLASM growth, tissue invasion, and METASTASIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Zhao, J1
Yan, Y2
Zhen, S1
Yu, L1
Ding, J1
Tang, Q1
Liu, L1
Zhu, H1
Xie, M1
Liang, Y1
Ding, T1
Chu, H1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Cancer Pain

ArticleYear
LY294002 alleviates bone cancer pain by reducing mitochondrial dysfunction and the inflammatory response.
    International journal of molecular medicine, 2023, Volume: 51, Issue:5

    Topics: Animals; Bone Neoplasms; Cancer Pain; Disabled Persons; Humans; Mitochondria; Motor Disorders; Neura

2023
PI3K/Akt signaling pathway may be involved in MCP-1-induced P2X4R expression in cultured microglia and cancer-induced bone pain rats.
    Neuroscience letters, 2019, 05-14, Volume: 701

    Topics: Animals; Benzoxazines; Calcium-Binding Proteins; Cancer Pain; Cell Line, Tumor; Chemokine CCL2; Chro

2019